LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 102 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2018. The put-call ratio across all filers is 4.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,230,000 | -40.2% | 41,310 | -35.3% | 0.03% | -42.3% |
| Q4 2017 | $2,056,000 | +4.8% | 63,895 | +13.3% | 0.05% | +18.2% |
| Q3 2017 | $1,961,000 | +19.1% | 56,371 | +1.9% | 0.04% | +12.8% |
| Q2 2017 | $1,647,000 | +3.7% | 55,309 | +4.0% | 0.04% | -4.9% |
| Q1 2017 | $1,588,000 | – | 53,190 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
| TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
| FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
| WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
| Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |